Class information for:
Level 1: PACAP//PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE//VIP

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
1356 2700 43.9 89%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
209 3       GHRELIN//ADRENOMEDULLIN//NEUROPEPTIDE Y 51926
2027 2             PACAP//PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE//VIP 5415
1356 1                   PACAP//PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE//VIP 2700

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PACAP authKW 4779925 22% 73% 583
2 PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE authKW 1718038 8% 73% 207
3 VIP authKW 984171 10% 31% 279
4 US J AN BIOMED S address 637125 3% 78% 72
5 PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE PACAP authKW 607950 3% 79% 68
6 HEBERT address 479169 2% 76% 56
7 PAC1 RECEPTOR authKW 394468 2% 81% 43
8 PACAP RECEPTOR authKW 393296 1% 87% 40
9 VASOACTIVE INTESTINAL PEPTIDE authKW 373532 7% 17% 192
10 PAC1 authKW 339330 2% 61% 49

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Endocrinology & Metabolism 15789 30% 0% 807
2 Neurosciences 8941 34% 0% 929
3 Biochemistry & Molecular Biology 3861 34% 0% 907
4 Physiology 2845 12% 0% 323
5 Pharmacology & Pharmacy 2734 20% 0% 552
6 Cell Biology 782 11% 0% 286
7 Immunology 182 6% 0% 158
8 Gastroenterology & Hepatology 170 3% 0% 87
9 Biophysics 147 4% 0% 103
10 Medicine, Research & Experimental 130 4% 0% 103

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 US J AN BIOMED S 637125 3% 78% 72
2 HEBERT 479169 2% 76% 56
3 PTE MTA LENDULET PAC TEAM 206256 1% 79% 23
4 SPORTBIOL 148533 1% 77% 17
5 SECT DEV MOL PHARMACOL 137357 1% 45% 27
6 NEUROHUMORAL REGULAT GRP 124361 1% 50% 22
7 EXPT ZOOL NEUROBIOL 114537 1% 35% 29
8 MOL NEUROPHARMACOL 102947 3% 11% 80
9 PARASITOL BIOMED 66869 1% 18% 33
10 EUROPEAN PEPTIDE 63220 1% 17% 32

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF MOLECULAR NEUROSCIENCE 81547 5% 5% 140
2 REGULATORY PEPTIDES 56724 6% 3% 154
3 PEPTIDES 49519 7% 2% 196
4 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 18047 9% 1% 253
5 NEUROPEPTIDES 9769 2% 2% 47
6 BIOMEDICAL RESEARCH-TOKYO 3154 1% 1% 28
7 ENDOCRINOLOGY 2730 3% 0% 79
8 JOURNAL OF NEUROENDOCRINOLOGY 1686 1% 1% 22
9 NEUROTOXICITY RESEARCH 1640 0% 1% 12
10 NEUROSCIENCE 1206 2% 0% 50

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 PACAP 4779925 22% 73% 583 Search PACAP Search PACAP
2 PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 1718038 8% 73% 207 Search PITUITARY+ADENYLATE+CYCLASE+ACTIVATING+POLYPEPTIDE Search PITUITARY+ADENYLATE+CYCLASE+ACTIVATING+POLYPEPTIDE
3 VIP 984171 10% 31% 279 Search VIP Search VIP
4 PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE PACAP 607950 3% 79% 68 Search PITUITARY+ADENYLATE+CYCLASE+ACTIVATING+POLYPEPTIDE+PACAP Search PITUITARY+ADENYLATE+CYCLASE+ACTIVATING+POLYPEPTIDE+PACAP
5 PAC1 RECEPTOR 394468 2% 81% 43 Search PAC1+RECEPTOR Search PAC1+RECEPTOR
6 PACAP RECEPTOR 393296 1% 87% 40 Search PACAP+RECEPTOR Search PACAP+RECEPTOR
7 VASOACTIVE INTESTINAL PEPTIDE 373532 7% 17% 192 Search VASOACTIVE+INTESTINAL+PEPTIDE Search VASOACTIVE+INTESTINAL+PEPTIDE
8 PAC1 339330 2% 61% 49 Search PAC1 Search PAC1
9 PACAP 38 266357 1% 67% 35 Search PACAP+38 Search PACAP+38
10 VPAC1 RECEPTOR 260729 1% 82% 28 Search VPAC1+RECEPTOR Search VPAC1+RECEPTOR

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 VAUDRY, D , FALLUEL-MOREL, A , BOURGAULT, S , BASILLE, M , BUREL, D , WURTZ, O , FOURNIER, A , CHOW, BKC , HASHIMOTO, H , GALAS, L , ET AL (2009) PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE AND ITS RECEPTORS: 20 YEARS AFTER THE DISCOVERY.PHARMACOLOGICAL REVIEWS. VOL. 61. ISSUE 3. P. 283 -357 973 73% 353
2 VAUDRY, D , GONZALEZ, BJ , BASILLE, M , YON, L , FOURNIER, A , VAUDRY, H , (2000) PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE AND ITS RECEPTORS: FROM STRUCTURE TO FUNCTIONS.PHARMACOLOGICAL REVIEWS. VOL. 52. ISSUE 2. P. 269 -324 589 70% 815
3 GONZALEZ, BJ , BASILLE, M , VAUDRY, D , FOURNIER, A , VAUDRY, H , (1998) PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE.ANNALES D ENDOCRINOLOGIE. VOL. 59. ISSUE 5. P. 364 -405 341 78% 16
4 SOMOGYVARI-VIGH, A , REGLODI, D , (2004) PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE: A POTENTIAL NEUROPROTECTIVE PEPTIDE.CURRENT PHARMACEUTICAL DESIGN. VOL. 10. ISSUE 23. P. 2861-2889 228 77% 151
5 SHERWOOD, NM , KRUECKL, SL , MCRORY, JE , (2000) THE ORIGIN AND FUNCTION OF THE PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP)/GLUCAGON SUPERFAMILY.ENDOCRINE REVIEWS. VOL. 21. ISSUE 6. P. 619 -670 288 49% 467
6 REGLODI, D , KISS, P , LUBICS, A , TAMAS, A , (2011) REVIEW ON THE PROTECTIVE EFFECTS OF PACAP IN MODELS OF NEURODEGENERATIVE DISEASES IN VITRO AND IN VIVO.CURRENT PHARMACEUTICAL DESIGN. VOL. 17. ISSUE 10. P. 962-972 145 83% 55
7 HARMAR, AJ , FAHRENKRUG, J , GOZES, I , LABURTHE, M , MAY, V , PISEGNA, JR , VAUDRY, D , VAUDRY, H , WASCHEK, JA , SAID, SI , (2012) PHARMACOLOGY AND FUNCTIONS OF RECEPTORS FOR VASOACTIVE INTESTINAL PEPTIDE AND PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE: IUPHAR REVIEW 1.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 166. ISSUE 1. P. 4 -17 130 76% 82
8 DICKSON, L , FINLAYSON, K , (2009) VPAC AND PAC RECEPTORS: FROM LIGANDS TO FUNCTION.PHARMACOLOGY & THERAPEUTICS. VOL. 121. ISSUE 3. P. 294 -316 179 57% 157
9 SEABORN, T , MASMOUDI-KOULI, O , FOURNIER, A , VAUDRY, H , VAUDRY, D , (2011) PROTECTIVE EFFECTS OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AGAINST APOPTOSIS.CURRENT PHARMACEUTICAL DESIGN. VOL. 17. ISSUE 3. P. 204-214 138 83% 34
10 ZHOU, CJ , SHIODA, S , YADA, T , INAGAKI, N , PLEASURE, SJ , KIKUYAMA, S , (2002) PACAP AND ITS RECEPTORS EXERT PLEIOTROPIC EFFECTS IN THE NERVOUS SYSTEM BY ACTIVATING MULTIPLE SIGNALING PATHWAYS.CURRENT PROTEIN & PEPTIDE SCIENCE. VOL. 3. ISSUE 4. P. 423 -439 187 78% 77

Classes with closest relation at Level 1


Rank Class id link
1 12837 HELODERMIN//VIP RECEPTOR//VASOACTIVE INTESTINAL PEPTIDE
2 26458 ADAMS SUPER BRAIN STUDIES//LILY AVRAHAM GILDOR CHAIR INVEST GROWTH TORS//ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN
3 15342 PREPRO VIP MESSENGER RNA//VIP PRECURSOR//CNRS ERA 484
4 20289 SECRETIN RECEPTOR//SECRETIN//SECRETIN ANALOGUES
5 28712 ENDOCRINE POLYPEPTIDE CANC//GHRH ANTAGONISTS//GROWTH HORMONE RELEASING HORMONE ANTAGONIST
6 21929 GASTRIC SODIUM MONITOR//ACETYLCHOLINESTERASE POSITIVE NERVE//HUMAN VALVE STUDY
7 11446 PNEUMADIN//ADRENAL INNERVATION//LIPID CYTOPLASM RATIO
8 19948 TRANSMITTER PLASTICITY//NEUROTRANSMITTER PLASTICITY//CHOLINERGIC FACTOR
9 6119 INHIBITORY JUNCTION POTENTIAL//NONADRENERGIC NONCHOLINERGIC NERVES//NITRERGIC NEUROTRANSMISSION
10 22257 OVARIAN NEURONS//RL SMITH MENTAL RETARDAT//HUMAN CERVICAL RIPENING

Go to start page